The AGITG welcomes the recent announcement by Minister Hunt, Federal Minister of Health, of a $33 million funding package to lift clinical trials and registries capacity and better support clinician researchers.
This is a critical first step towards ensuring health and medical research is focused on maximising public benefit.
As part of this announcement the Australian Clinical Trials Alliance (ACTA) will receive $5M of funding over 4 years to enhance the capacity of trials networks to conduct public good trials. The funding also included $13 million to establish a new competitive grant program for clinical trials and $8 million to increase the number of clinical research fellowships supported by the National Health & Medical Research Council (NHMRC).
This investment strategically builds on the Government’s 2016 Encouraging more clinical trials in Australia initiative that seeks to streamline trial operations to improve start-up and recruitment efforts.
As outlined by ACTA, this announcement acknowledges the critical unmet need for better evidence to improve health outcomes for Australians and that clinical trials networks (CTN’s) are best placed to meet this unmet need.
The AGITG is one of more than 50 clinical trial networks (CTN’s) who form membership of ACTA. As the national peak body, ACTA promote effective and cost‐effective healthcare in Australia through investigator‐initiated clinical trials and clinical quality registries that generate evidence to support decisions made by health practitioners, policy‐makers, and consumers.
The AGITG is looking forward to its continued work with ACTA to help inform enhancements to the effectiveness and efficiency of our sector, as well as playing our part in identifying and answering the research questions that are of the highest priority in order to ensure the implementation of trial results into clinical practice and policy.